 | • レポートコード：QY20ST-06230 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の肺炎ワクチン市場について種類別（肺炎球菌ワクチン（PCV13）、肺炎球菌多糖ワクチン（PPSV23））、用途別（肺炎、髄膜炎、敗血症）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・肺炎ワクチン市場の概要 ・世界の主要地域別肺炎ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の肺炎ワクチン市場規模2015-2026：種類別（肺炎球菌ワクチン（PCV13）、肺炎球菌多糖ワクチン（PPSV23）） ・世界の肺炎ワクチン市場規模2015-2026：用途別（肺炎、髄膜炎、敗血症） ・肺炎ワクチンの北米市場規模2015-2020 ・肺炎ワクチンのヨーロッパ市場規模2015-2020 ・肺炎ワクチンの中国市場規模2015-2020 ・肺炎ワクチンの日本市場規模2015-2020 ・肺炎ワクチンの東南アジア市場規模2015-2020 ・肺炎ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・肺炎ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・肺炎ワクチンの市場動向・機会・課題 ・調査の結論 |
Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Center for Disease Control and Prevention (CDC) recommends administration of two pneumococcal vaccines.
Market Analysis and Insights: Global Pneumonia Vaccine Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Pneumonia Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Pneumonia Vaccine industry.
Based on our recent survey, we have several different scenarios about the Pneumonia Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Pneumonia Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Pneumonia Vaccine Scope and Market Size
The global Pneumonia Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pneumonia Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pneumonia Vaccine market is segmented into
Pneumococcal Conjugate Vaccine (PCV13)
Pneumococcal Polysaccharide Vaccine (PPSV23)
Segment by Application, the Pneumonia Vaccine market is segmented into
Pneumonia
Meningitis
Sepsis
The Pneumonia Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Pneumonia Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pneumonia Vaccine Market Share Analysis
Pneumonia Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pneumonia Vaccine business, the date to enter into the Pneumonia Vaccine market, Pneumonia Vaccine product introduction, recent developments, etc.
The major vendors covered:
Pfizer Inc.
Glaxosmithkline Plc.
Merck & Co., Inc.
Sanofi Pasteur
Serum Institute of India Pvt. Ltd.
Johnson & Johnson
Astellas Pharma Inc.
Astrazeneca Plc.
CSL Limited
Emergent Biosolutions
1 Pneumonia Vaccine Market Overview
1.1 Pneumonia Vaccine Product Scope
1.2 Pneumonia Vaccine Segment by Type
1.2.1 Global Pneumonia Vaccine Sales by Type (2020-2026)
1.2.2 Pneumococcal Conjugate Vaccine (PCV13)
1.2.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
1.3 Pneumonia Vaccine Segment by Application
1.3.1 Global Pneumonia Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Sepsis
1.4 Pneumonia Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Pneumonia Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Pneumonia Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Pneumonia Vaccine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Pneumonia Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Pneumonia Vaccine Industry
1.5.1.1 Pneumonia Vaccine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Pneumonia Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Pneumonia Vaccine Players to Combat Covid-19 Impact
2 Pneumonia Vaccine Estimate and Forecast by Region
2.1 Global Pneumonia Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Pneumonia Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Pneumonia Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Pneumonia Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Pneumonia Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Pneumonia Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Pneumonia Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Pneumonia Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Pneumonia Vaccine Estimates and Projections (2015-2026)
2.4.3 China Pneumonia Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Pneumonia Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Pneumonia Vaccine Estimates and Projections (2015-2026)
2.4.6 India Pneumonia Vaccine Estimates and Projections (2015-2026)
3 Global Pneumonia Vaccine Competition Landscape by Players
3.1 Global Top Pneumonia Vaccine Players by Sales (2015-2020)
3.2 Global Top Pneumonia Vaccine Players by Revenue (2015-2020)
3.3 Global Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia Vaccine as of 2019)
3.4 Global Pneumonia Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Pneumonia Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Pneumonia Vaccine Players (Opinion Leaders)
4 Global Pneumonia Vaccine Market Size by Type
4.1 Global Pneumonia Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Pneumonia Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Pneumonia Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Pneumonia Vaccine Price by Type (2014-2020)
4.2 Global Pneumonia Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Pneumonia Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Pneumonia Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Pneumonia Vaccine Price Forecast by Type (2021-2026)
5 Global Pneumonia Vaccine Market Size by Application
5.1 Global Pneumonia Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Pneumonia Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Pneumonia Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Pneumonia Vaccine Price by Application (2015-2020)
5.2 Global Pneumonia Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Pneumonia Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Pneumonia Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Pneumonia Vaccine Price Forecast by Application (2021-2026)
3 North America Pneumonia Vaccine Market Facts & Figures
3.2 North America Pneumonia Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Pneumonia Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Pneumonia Vaccine Sales Market Share by Application (2015-2020)
4 Europe Pneumonia Vaccine Market Facts & Figures
4.2 Europe Pneumonia Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Pneumonia Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Pneumonia Vaccine Sales Market Share by Application (2015-2020)
5 China Pneumonia Vaccine Market Facts & Figures
5.2 China Pneumonia Vaccine Sales Market Share by Company (2015-2020)
5.3 China Pneumonia Vaccine Sales Market Share by Type (2015-2020)
5.4 China Pneumonia Vaccine Sales Market Share by Application (2015-2020)
6 Japan Pneumonia Vaccine Market Facts & Figures
6.2 Japan Pneumonia Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Pneumonia Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Pneumonia Vaccine Sales Market Share by Application (2015-2020)
7 Southeast Asia Pneumonia Vaccine Market Facts & Figures
7.2 Southeast Asia Pneumonia Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Pneumonia Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Pneumonia Vaccine Sales Market Share by Application (2015-2020)
8 India Pneumonia Vaccine Market Facts & Figures
8.2 India Pneumonia Vaccine Sales Market Share by Company (2015-2020)
8.3 India Pneumonia Vaccine Sales Market Share by Type (2015-2020)
8.4 India Pneumonia Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Pneumonia Vaccine Business
12.1 Pfizer Inc.
12.1.1 Pfizer Inc. Pneumonia Vaccine Corporation Information
12.1.2 Pfizer Inc. Pneumonia Vaccine Business Overview and Total Revenue
12.1.3 Pfizer Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Inc. Pneumonia Vaccine Products Offered
12.1.5 Pfizer Inc. Recent Development
12.2 Glaxosmithkline Plc.
12.2.1 Glaxosmithkline Plc. Pneumonia Vaccine Corporation Information
12.2.2 Glaxosmithkline Plc. Pneumonia Vaccine Business Overview and Total Revenue
12.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Glaxosmithkline Plc. Pneumonia Vaccine Products Offered
12.2.5 Glaxosmithkline Plc. Recent Development
12.3 Merck & Co., Inc.
12.3.1 Merck & Co., Inc. Pneumonia Vaccine Corporation Information
12.3.2 Merck & Co., Inc. Pneumonia Vaccine Business Overview and Total Revenue
12.3.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck & Co., Inc. Pneumonia Vaccine Products Offered
12.3.5 Merck & Co., Inc. Recent Development
12.4 Sanofi Pasteur
12.4.1 Sanofi Pasteur Pneumonia Vaccine Corporation Information
12.4.2 Sanofi Pasteur Pneumonia Vaccine Business Overview and Total Revenue
12.4.3 Sanofi Pasteur Pneumonia Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofi Pasteur Pneumonia Vaccine Products Offered
12.4.5 Sanofi Pasteur Recent Development
12.5 Serum Institute of India Pvt. Ltd.
12.5.1 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Corporation Information
12.5.2 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Business Overview and Total Revenue
12.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Products Offered
12.5.5 Serum Institute of India Pvt. Ltd. Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Pneumonia Vaccine Corporation Information
12.6.2 Johnson & Johnson Pneumonia Vaccine Business Overview and Total Revenue
12.6.3 Johnson & Johnson Pneumonia Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Johnson & Johnson Pneumonia Vaccine Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 Astellas Pharma Inc.
12.7.1 Astellas Pharma Inc. Pneumonia Vaccine Corporation Information
12.7.2 Astellas Pharma Inc. Pneumonia Vaccine Business Overview and Total Revenue
12.7.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Astellas Pharma Inc. Pneumonia Vaccine Products Offered
12.7.5 Astellas Pharma Inc. Recent Development
12.8 Astrazeneca Plc.
12.8.1 Astrazeneca Plc. Pneumonia Vaccine Corporation Information
12.8.2 Astrazeneca Plc. Pneumonia Vaccine Business Overview and Total Revenue
12.8.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Astrazeneca Plc. Pneumonia Vaccine Products Offered
12.8.5 Astrazeneca Plc. Recent Development
12.9 CSL Limited
12.9.1 CSL Limited Pneumonia Vaccine Corporation Information
12.9.2 CSL Limited Pneumonia Vaccine Business Overview and Total Revenue
12.9.3 CSL Limited Pneumonia Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 CSL Limited Pneumonia Vaccine Products Offered
12.9.5 CSL Limited Recent Development
12.10 Emergent Biosolutions
12.10.1 Emergent Biosolutions Pneumonia Vaccine Corporation Information
12.10.2 Emergent Biosolutions Pneumonia Vaccine Business Overview and Total Revenue
12.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Emergent Biosolutions Pneumonia Vaccine Products Offered
12.10.5 Emergent Biosolutions Recent Development
13 Pneumonia Vaccine Manufacturing Cost Analysis
13.1 Pneumonia Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pneumonia Vaccine
13.4 Pneumonia Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pneumonia Vaccine Distributors List
14.3 Pneumonia Vaccine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Pneumonia Vaccine Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Pneumonia Vaccine Sales (K Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Pneumonia Vaccine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Pneumonia Vaccine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Pneumonia Vaccine Players to Combat Covid-19 Impact
Table 8. Global Market Pneumonia Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Pneumonia Vaccine Sales (K Doses) by Region (2015-2020)
Table 10. Global Pneumonia Vaccine Sales Market Share by Region (2015-2020)
Table 11. Global Pneumonia Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Pneumonia Vaccine Revenue Share by Region (2015-2020)
Table 13. Global Pneumonia Vaccine Sales (K Doses) Forecast by Region (2021-2026)
Table 14. Global Pneumonia Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Pneumonia Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Pneumonia Vaccine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Pneumonia Vaccine (K Doses) of Key Companies (2015-2020)
Table 18. Global Pneumonia Vaccine Sales Share by Company (2015-2020)
Table 19. Global Pneumonia Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Pneumonia Vaccine Revenue Share by Company (2015-2020)
Table 21. Global Pneumonia Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia Vaccine as of 2019)
Table 22. Global Pneumonia Vaccine Average Price (USD/Dose) of Key Company (2015-2020)
Table 23. Manufacturers Pneumonia Vaccine Manufacturing Sites and Area Served
Table 24. Manufacturers Pneumonia Vaccine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Pneumonia Vaccine Players
Table 27. Global Pneumonia Vaccine Sales (K Doses) by Type (2015-2020)
Table 28. Global Pneumonia Vaccine Sales Share by Type (2015-2020)
Table 29. Global Pneumonia Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Pneumonia Vaccine Price (K Doses) by Type (2015-2020)
Table 31. Global Pneumonia Vaccine Sales Share by Type (2021-2026)
Table 32. Global Pneumonia Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Pneumonia Vaccine Revenue Share by Type (2021-2026)
Table 34. Global Pneumonia Vaccine Price (K Doses) by Type (2021-2026)
Table 35. Global Pneumonia Vaccine Sales (K Doses) by Application (2015-2020)
Table 36. Global Pneumonia Vaccine Sales Share by Application (2015-2020)
Table 37. Global Pneumonia Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Pneumonia Vaccine Price (K Doses) by Application (2015-2020)
Table 39. Global Pneumonia Vaccine Sales (K Doses) by Application (2021-2026)
Table 40. Global Pneumonia Vaccine Sales Share by Application (2021-2026)
Table 41. Global Pneumonia Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Pneumonia Vaccine Revenue Share by Application (2021-2026)
Table 43. Global Pneumonia Vaccine Price (K Doses) by Application (2021-2026)
Table 44. United States Pneumonia Vaccine Sales (K Doses) by Company (2015-2020)
Table 45. United States Pneumonia Vaccine Sales Market Share by Company (2015-2020)
Table 46. United States Pneumonia Vaccine Sales (K Doses) by Type (2015-2020)
Table 47. United States Pneumonia Vaccine Sales Market Share by Type (2015-2020)
Table 48. United States Pneumonia Vaccine Sales (K Doses) by Application (2015-2020)
Table 49. United States Pneumonia Vaccine Sales Market Share by Application (2015-2020)
Table 50. Europe Pneumonia Vaccine Sales (K Doses) by Company (2015-2020)
Table 51. Europe Pneumonia Vaccine Sales Market Share by Company (2015-2020)
Table 52. Europe Pneumonia Vaccine Sales (K Doses) by Type (2015-2020)
Table 53. Europe Pneumonia Vaccine Sales Market Share by Type (2015-2020)
Table 54. Europe Pneumonia Vaccine Sales (K Doses) by Application (2015-2020)
Table 55. Europe Pneumonia Vaccine Sales Market Share by Type (2015-2020)
Table 56. China Pneumonia Vaccine Sales (K Doses) by Company (2015-2020)
Table 57. China Pneumonia Vaccine Sales Market Share by Company (2015-2020)
Table 58. China Pneumonia Vaccine Sales (K Doses) by Type (2015-2020)
Table 59. China Pneumonia Vaccine Sales Market Share by Type (2015-2020)
Table 60. China Pneumonia Vaccine Sales (K Doses) by Application (2015-2020)
Table 61. China Pneumonia Vaccine Sales Market Share by Application (2015-2020)
Table 62. Japan Pneumonia Vaccine Sales (K Doses) by Company (2015-2020)
Table 63. Japan Pneumonia Vaccine Sales Market Share by Company (2015-2020)
Table 64. Japan Pneumonia Vaccine Sales (K Doses) by Type (2015-2020)
Table 65. Japan Pneumonia Vaccine Sales Market Share by Type (2015-2020)
Table 66. Japan Pneumonia Vaccine Sales (K Doses) by Application (2015-2020)
Table 67. Japan Pneumonia Vaccine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Pneumonia Vaccine Sales (K Doses) by Company (2015-2020)
Table 69. Southeast Asia Pneumonia Vaccine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Pneumonia Vaccine Sales (K Doses) by Type (2015-2020)
Table 71. Southeast Asia Pneumonia Vaccine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Pneumonia Vaccine Sales (K Doses) by Type (2015-2020)
Table 73. Southeast Asia Pneumonia Vaccine Sales Market Share by Application (2015-2020)
Table 74. India Pneumonia Vaccine Sales (K Doses) by Company (2015-2020)
Table 75. India Pneumonia Vaccine Sales Market Share by Company (2015-2020)
Table 76. India Pneumonia Vaccine Sales (K Doses) by Type (2015-2020)
Table 77. India Pneumonia Vaccine Sales Market Share by Type (2015-2020)
Table 78. India Pneumonia Vaccine Sales (K Doses) by Application (2015-2020)
Table 79. India Pneumonia Vaccine Sales Market Share by Application (2015-2020)
Table 80. Pfizer Inc. Corporation Information
Table 81. Pfizer Inc. Description and Business Overview
Table 82. Pfizer Inc. Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Pfizer Inc. Pneumonia Vaccine Product
Table 84. Pfizer Inc. Recent Development
Table 85. Glaxosmithkline Plc. Corporation Information
Table 86. Glaxosmithkline Plc. Description and Business Overview
Table 87. Glaxosmithkline Plc. Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Glaxosmithkline Plc. Pneumonia Vaccine Product
Table 89. Glaxosmithkline Plc. Recent Development
Table 90. Merck & Co., Inc. Corporation Information
Table 91. Merck & Co., Inc. Description and Business Overview
Table 92. Merck & Co., Inc. Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Merck & Co., Inc. Pneumonia Vaccine Product
Table 94. Merck & Co., Inc. Recent Development
Table 95. Sanofi Pasteur Corporation Information
Table 96. Sanofi Pasteur Description and Business Overview
Table 97. Sanofi Pasteur Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Sanofi Pasteur Pneumonia Vaccine Product
Table 99. Sanofi Pasteur Recent Development
Table 100. Serum Institute of India Pvt. Ltd. Corporation Information
Table 101. Serum Institute of India Pvt. Ltd. Description and Business Overview
Table 102. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product
Table 104. Serum Institute of India Pvt. Ltd. Recent Development
Table 105. Johnson & Johnson Corporation Information
Table 106. Johnson & Johnson Description and Business Overview
Table 107. Johnson & Johnson Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Johnson & Johnson Pneumonia Vaccine Product
Table 109. Johnson & Johnson Recent Development
Table 110. Astellas Pharma Inc. Corporation Information
Table 111. Astellas Pharma Inc. Description and Business Overview
Table 112. Astellas Pharma Inc. Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Astellas Pharma Inc. Pneumonia Vaccine Product
Table 114. Astellas Pharma Inc. Recent Development
Table 115. Astrazeneca Plc. Corporation Information
Table 116. Astrazeneca Plc. Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Astrazeneca Plc. Description and Business Overview
Table 118. Astrazeneca Plc. Pneumonia Vaccine Product
Table 119. Astrazeneca Plc. Recent Development
Table 120. CSL Limited Corporation Information
Table 121. CSL Limited Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 122. CSL Limited Description and Business Overview
Table 123. CSL Limited Pneumonia Vaccine Product
Table 124. CSL Limited Recent Development
Table . Emergent Biosolutions Corporation Information
Table . Emergent Biosolutions Description and Business Overview
Table . Emergent Biosolutions Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table . Emergent Biosolutions Pneumonia Vaccine Product
Table . Emergent Biosolutions Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Pneumonia Vaccine Distributors List
Table 133. Pneumonia Vaccine Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumonia Vaccine Product Picture
Figure 2. Global Pneumonia Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pneumonia Vaccine Market Share by Application in 2020 & 2026
Figure 6. Pneumonia Examples
Figure 7. Meningitis Examples
Figure 8. Sepsis Examples
Figure 9. Global Pneumonia Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 10. Global Pneumonia Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Pneumonia Vaccine Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 12. Global Pneumonia Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Pneumonia Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Pneumonia Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Pneumonia Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 16. Europe Pneumonia Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Pneumonia Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Pneumonia Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Pneumonia Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Pneumonia Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Pneumonia Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Pneumonia Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Pneumonia Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Pneumonia Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Pneumonia Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Pneumonia Vaccine Players Market Share by Revenue in Pneumonia Vaccine 2015 & 2019
Figure 27. Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Pneumonia Vaccine Revenue Share by Type (2015-2020)
Figure 29. Global Pneumonia Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Pneumonia Vaccine Revenue Share by Application (2015-2020)
Figure 31. Global Pneumonia Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Pneumonia Vaccine Sales Market Share by Type in 2019
Figure 33. United States Pneumonia Vaccine Sales Market Share by Type in 2019
Figure 34. Europe Pneumonia Vaccine Sales Market Share by Company in 2019
Figure 35. Europe Pneumonia Vaccine Sales Market Share by Type in 2019
Figure 36. Europe Pneumonia Vaccine Sales Market Share by Application in 2019
Figure 37. China Pneumonia Vaccine Sales Market Share by Company in 2019
Figure 38. China Pneumonia Vaccine Sales Market Share by Type in 2019
Figure 39. China Pneumonia Vaccine Sales Market Share by Application in 2019
Figure 40. Japan Pneumonia Vaccine Sales Market Share by Company in 2019
Figure 41. Japan Pneumonia Vaccine Sales Market Share by Type in 2019
Figure 42. Japan Pneumonia Vaccine Sales Market Share by Application in 2019
Figure 43. Southeast Asia Pneumonia Vaccine Sales Market Share by Company in 2019
Figure 44. Southeast Asia Pneumonia Vaccine Sales Market Share by Type in 2019
Figure 45. Southeast Asia Pneumonia Vaccine Sales Market Share by Application in 2019
Figure 46. India Pneumonia Vaccine Sales Market Share by Company in 2019
Figure 47. India Pneumonia Vaccine Sales Market Share by Type in 2019
Figure 48. India Pneumonia Vaccine Sales Market Share by Application in 2019
Figure 49. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Glaxosmithkline Plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Serum Institute of India Pvt. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Astellas Pharma Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Astrazeneca Plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. CSL Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Emergent Biosolutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Pneumonia Vaccine
Figure 61. Manufacturing Process Analysis of Pneumonia Vaccine
Figure 62. Pneumonia Vaccine Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
帯状疱疹ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Shingles Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Shingles Vaccine market repo…- 遺伝ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Genetic Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate da…
- パンデミックインフルエンザワクチンの世界市場レポート2020 Influenza vaccines treat influenza by developing antibodies in the body within two weeks after vaccination. These antibodies protect against infections with the help of the attenuated viruses in the vaccine. These vaccines contain killed or inactivated strains of the influenza virus. Market Analysis…
- ピーナッツアレルギーワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Peanut Allergy Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Peanut Allergy Vaccine…
- 組換えタンパク質ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Recombinant Protein Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides…